Safer alternative to heparin identified.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D017984:Enoxaparin / Q000009:adverse effects*; D000077425:Fondaparinux; D006801:Humans; D007866:Leg / Q000098:blood supply*; D011134:Polysaccharides / Q000627:therapeutic use*; D013927:Thrombosis / Q000401:mortality / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D011134:Polysaccharides; D000077425:Fondaparinux